Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05119933 |
| Title | A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Shanghai YingLi Pharmaceutical Co. Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Innovative Clinical Research Institute | NOT_YET_RECRUITING | Whittier | California | 90603 | United States | Details |
| The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai | NOT_YET_RECRUITING | New York | New York | 10029 | United States | Details |
| Oncology Consultants | RECRUITING | Houston | Texas | 77584 | United States | Details |